par Catteau, Lucy;Dauby, Nicolas
;Montourcy, Marion;Bottieau, Emmanuel;Hautekiet, Joris;Goetghebeur, Els;van Ierssel, Sabrina;Duysburgh, E;Van Oyen, Herman;Wyndham-Thomas, Chloe
;Van Beckhoven, Dominique;Belgian Collaborative Group on COVID-19 Hospital Surveillance,
Référence International journal of antimicrobial agents, 56, 4, page (106144)
Publication Publié, 2020-10


Référence International journal of antimicrobial agents, 56, 4, page (106144)
Publication Publié, 2020-10
Article révisé par les pairs
Titre: |
|
Auteur: | Catteau, Lucy; Dauby, Nicolas; Montourcy, Marion; Bottieau, Emmanuel; Hautekiet, Joris; Goetghebeur, Els; van Ierssel, Sabrina; Duysburgh, E; Van Oyen, Herman; Wyndham-Thomas, Chloe; Van Beckhoven, Dominique; Belgian Collaborative Group on COVID-19 Hospital Surveillance, |
Informations sur la publication: | International journal of antimicrobial agents, 56, 4, page (106144) |
Statut de publication: | Publié, 2020-10 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | COVID-19 |
Hydroxychloroquine | |
Mortality | |
Observational study | |
SARS-CoV-2 | |
MeSH keywords: | Adolescent |
Adult | |
Aged | |
Aged, 80 and over | |
Antimalarials -- therapeutic use | |
Betacoronavirus -- drug effects -- pathogenicity | |
C-Reactive Protein -- metabolism | |
Coronavirus Infections -- diagnostic imaging -- drug therapy -- mortality -- pathology | |
Disease Progression | |
Drug Dosage Calculations | |
Drug Repositioning | |
Female | |
Hospital Mortality | |
Humans | |
Hydroxychloroquine -- therapeutic use | |
Intensive Care Units | |
Male | |
Middle Aged | |
Pandemics | |
Patient Safety | |
Pneumonia, Viral -- diagnostic imaging -- drug therapy -- mortality -- pathology | |
Prognosis | |
Proportional Hazards Models | |
Retrospective Studies | |
T-Lymphocytes -- pathology -- virology | |
Tomography, X-Ray Computed | |
Treatment Outcome | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0924-8579 |
info:doi/10.1016/j.ijantimicag.2020.106144 | |
info:pii/S0924-8579(20)30342-3 | |
info:scp/85090488256 | |
info:pmid/32853673 | |
PMC7444610 |